Great questions, as I had pretty much the same thoughts. I will ask him all about the Hemp Oil-based supplements and where they are in the process. As for the medicine side, I previously spoke to him about that and they have no plans to get involved with the medicine side at this time, which would be a very lengthy and costly process to get FDA approval. To get involved with the medicine side would require substantial dilution to fund the studies and Mr. James will not go that route unless it would bring immediate value to shareholders and given the rigorous FDA approval process, it would not be a viable option at this time. However, it doesn't mean they would never look into this, just not at this time.
The authorized share count is at the top of my list to remind him about reducing the large authorized share count that was instituted by previous management. At the very least, it should be reduced by 50%. Personally I would like to see it reduced down to 100 million, but I will be fine by whatever Mr. James decides to do. He is an expert in the financial arena and he will do what is best for the business and the shareholders.
Thanks again for your great questions. I should have a summary posted of our conversation sometime this weekend. Cheers!
News 
Market Data 
Discover 
